AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Generic allegra-D approved.(PRODUCTS)

OB GYN News

| June 01, 2005 | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

A combination of fexofenadine HCl and pseudoephedrine HCl in an extended-release tablet (60 mg/120 mg) is indicated for the relief of symptoms associated with ...

Related articles from newspapers, magazines, journals, and more
Generic Allegra 60 mg gains FDA approval.(PIPELINE PREVIEWS)
Magazine article from: Journal of Drugs in Dermatology November 1, 2005 700+ words
Barr Pharmaceuticals, Inc., recently received FDA approval to market a generic...initiating a lawsuit, citing patent infringement. Although Barr Pharmaceuticals has received FDA approval, it plans to delay marketing the...
Generic allegra-D approved.(PRODUCTS)(Brief Article)
Magazine article from: Internal Medicine News July 1, 2005 700+ words
...indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years and older. For more information, contact Barr Pharmaceuticals Inc. by calling 800-222-0190 or 201-930-3302.
IMPAX Files Motion to Intervene as Defendant in Litigation Related to Generic...
Press release article from: Business Wire February 28, 2005 700+ words
...United States Food and Drug Administration (FDA). Earlier this month, Barr Laboratories, a subsidiary of Barr Pharmaceuticals, Inc. (NYSE:BRL), brought suit against the FDA in an attempt to prevent the agency from granting final...
Barr eligible for exclusivity on generic Allegra-D.(Barr Laboratories...
Newspaper article from: Pharma Marketletter April 18, 2005 700+ words
...s shared exclusivity policy in connection with Barr's generic Allegra-D 12-Hour (fexofenadine HCl/pseudoephedrine HCl...other applicant would be allowed to obtain approval for generic Allegra-D 12 Hour before Barr's 180-day period of exclusivity...
Dr Reddys gets USFDA approval for generic Allegra.
News wire article from: PTI - The Press Trust of India Ltd. April 13, 2006 700+ words
Dr Reddys gets USFDA approval for generic Allegra Mumbai, Apr 13 (PTI) Leading pharma company Dr Reddys Laboratories Ltd has received final approval from USFDA for its Abbreviated...
AMRI profit down in '06: One-time charges, launch of generic Allegra took toll...
Newspaper article from: Times Union (Albany, NY) February 13, 2007 700+ words
...s performance during 2006 has been largely overshadowed by the loss of royalty revenue from the 'at risk' launch of generic Allegra in September of 2005," said Thomas E. D'Ambra, the company's chairman, president and CEO. "We continue to vigorously...
Aventis, Barr Battle Over Generic Allegra.(Barr Laboratories, Aventis...
Magazine article from: Chemical Market Reporter July 9, 2001 700+ words
BARR LABORATORIES Inc. plans to challenge the patents protecting Allegra (fexofenadine), the anti-allergy drug by Aventis Pharma AG. The action follow Barr's filing of an abbreviated new drug application (ANDA) with the Food & Drug Administration (FDA) seeking authorization to produce and
Barr sues FDA over generic Allegra.(Food and Drug Administration)(BARR...
Newspaper article from: Pharma Marketletter February 14, 2005 700+ words
Barr Laboratories of the USA says it has filed a suit against the US Food and Drug Administration in the District Court of Columbia, challenging the agency's policy of awarding generic exclusivity on a patent-by-patent basis. The move follows Barr's application in September 2001 to market a generic
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA